John M Keith
Overview
Explore the profile of John M Keith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
192
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keith J, Jones W, Pierce J, Seierstad M, Palmer J, Webb M, et al.
Bioorg Med Chem Lett
. 2020 Aug;
30(20):127463.
PMID: 32784090
A series of mechanism-based heteroaryl urea fatty acid amide hydrolase (FAAH) inhibitors with fused bicyclic diamine cores is described. In contrast to compounds built around a piperazine core, most of...
2.
Keith J, Tichenor M, Apodaca R, Xiao W, Jones W, Seierstad M, et al.
Bioorg Med Chem Lett
. 2016 May;
26(13):3109-3114.
PMID: 27189675
The SAR of brain penetration for a series of heteroaryl piperazinyl- and piperadinyl-urea fatty acid amide hydrolase (FAAH) inhibitors is described. Brain/plasma (B/P) ratios ranging from >4:1 to as low...
3.
Blevitt J, Hack M, Herman K, Chang L, Keith J, Mirzadegan T, et al.
J Biol Chem
. 2016 Apr;
291(24):12724-12731.
PMID: 27129215
5-Lipoxygenase activating protein (FLAP) plays a critical role in the metabolism of arachidonic acid to leukotriene A4, the precursor to the potent pro-inflammatory mediators leukotriene B4 and leukotriene C4 Studies...
4.
Keith J, Jones W, Tichenor M, Liu J, Seierstad M, Palmer J, et al.
ACS Med Chem Lett
. 2015 Dec;
6(12):1204-8.
PMID: 26713105
The pre-clinical characterization of the aryl piperazinyl urea inhibitor of fatty acid amide hydrolase (FAAH) JNJ-42165279 is described. JNJ-42165279 covalently inactivates the FAAH enzyme, but is highly selective with regard...
5.
Song J, Liu X, Zhu J, Tootoonchi M, Keith J, Meduna S, et al.
J Biomol Screen
. 2015 Oct;
21(2):127-35.
PMID: 26442913
Leukotrienes (LTs) and related species are proinflammatory lipid mediators derived from arachidonic acid (AA) that have pathological roles in autoimmune and inflammatory conditions, cardiovascular diseases, and cancer. 5-Lipoxygenase activating protein...
6.
Keith J, Apodaca R, Tichenor M, Xiao W, Jones W, Pierce J, et al.
ACS Med Chem Lett
. 2014 Jun;
3(10):823-7.
PMID: 24900385
A series of aryl piperazinyl ureas that act as covalent inhibitors of fatty acid amide hydrolase (FAAH) is described. A potent and selective (does not inhibit FAAH-2) member of this...
7.
Keith J, Hawryluk N, Apodaca R, Chambers A, Pierce J, Seierstad M, et al.
Bioorg Med Chem Lett
. 2014 Feb;
24(5):1280-4.
PMID: 24513048
A series of 1-aryl-2-(((6-aryl)pyrimidin-4-yl)amino)ethanols have been found to be competitive inhibitors of fatty acid amide hydrolase (FAAH). One member of this class, JNJ-40413269, was found to have excellent pharmacokinetic properties,...
8.
Keith J, Jones W, Pierce J, Seierstad M, Palmer J, Webb M, et al.
Bioorg Med Chem Lett
. 2014 Jan;
24(3):737-41.
PMID: 24433863
A series of mechanism based heteroaryl urea fatty acid amide hydrolase (FAAH) inhibitors with spirocyclic diamine cores is described. A potent member of this class, (37), was found to inhibit...
9.
Keith J
J Org Chem
. 2012 Dec;
77(24):11313-8.
PMID: 23215457
Various pyridine, quinoline, isoquinoline, and pyrimidine N-oxides were converted to their corresponding α-N-aryltriflamidoheteroarenes in good yield by treatment with N-aryltriflimides, both neat and in solution, at temperatures ranging from rt...
10.
Tichenor M, Keith J, Jones W, Pierce J, Merit J, Hawryluk N, et al.
Bioorg Med Chem Lett
. 2012 Nov;
22(24):7357-62.
PMID: 23141911
The structure-activity relationships for a series of heteroaryl urea inhibitors of fatty acid amide hydrolase (FAAH) are described. Members of this class of inhibitors have been shown to inactivate FAAH...